Walleye Trading
NVCR icon

Walleye Trading’s NovoCure NVCR Stock Holding History

Walleye Trading’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,800
Closed -$53.6K – 4522
2024
Q4 		$53.6K Buy
+1,800
New +$38.1K ﹤0.01% 3778
2024
Q1 		– Sell
-4,700
Closed -$70.2K – 5150
2023
Q4 		$70.2K Sell
4,700
-4,300
-48% -$57.5K ﹤0.01% 4258
2023
Q3 		$145K Buy
+9,000
New +$259K ﹤0.01% 3793
2023
Q2 		– Sell
-19,100
Closed -$1.15M – 5034
2023
Q1 		$1.15M Buy
19,100
+11,800
+162% +$943K ﹤0.01% 2092
2022
Q4 		$535K Sell
7,300
-6,900
-49% -$519K ﹤0.01% 2753
2022
Q3 		$1.08M Buy
14,200
+100
+0.7% +$7.8K ﹤0.01% 2202
2022
Q2 		$980K Sell
14,100
-2,600
-16% -$196K ﹤0.01% 2242
2022
Q1 		$1.38M Buy
16,700
+8,400
+101% +$619K ﹤0.01% 1957
2021
Q4 		$623K Buy
8,300
+700
+9% +$70.3K ﹤0.01% 2725
2021
Q3 		$883K Sell
7,600
-500
-6% -$75.6K ﹤0.01% 2340
2021
Q2 		$1.8M Buy
8,100
+7,900
+3,950% +$1.54M 0.01% 1591
2021
Q1 		$26K Sell
200
-32,000
-99% -$5.06M ﹤0.01% 4491
2020
Q4 		$5.57M Sell
32,200
-30,200
-48% -$4.13M 0.02% 663
2020
Q3 		$6.95M Buy
62,400
+59,700
+2,211% +$4.77M 0.04% 423
2020
Q2 		$160K Sell
2,700
-3,900
-59% -$256K ﹤0.01% 3224
2020
Q1 		$444K Sell
6,600
-200
-3% -$15.8K ﹤0.01% 1967
2019
Q4 		$573K Sell
6,800
-54,000
-89% -$4.36M ﹤0.01% 2292
2019
Q3 		$4.55M Buy
60,800
+40,900
+206% +$3.27M 0.04% 515
2019
Q2 		$1.26M Sell
19,900
-76,100
-79% -$3.86M 0.01% 1405
2019
Q1 		$4.62M Buy
96,000
+81,100
+544% +$3.9M 0.04% 538
2018
Q4 		$499K Sell
14,900
-7,900
-35% -$289K ﹤0.01% 2481
2018
Q3 		$1.2M Buy
22,800
+14,500
+175% +$577K 0.01% 1886
2018
Q2 		$260K Sell
8,300
-514,100
-98% -$14.3M ﹤0.01% 3405
2018
Q1 		$11.4M Buy
522,400
+500,700
+2,307% +$10.8M 0.07% 229
2017
Q4 		$438 Buy
+21,700
New +$418K ﹤0.01% 2726

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Walleye Trading's NVCR Position: Q1 2026 in Review

Walleye Trading sold out of NovoCure (NVCR) in Q1 2026, closing a stake of 25,808 shares — an estimated $334K sold.

Walleye Trading first reported a position in NVCR in Q4 2018 and held it in 14 quarters. The position peaked at $2.04M in Q2 2021. 222 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

  • Walleye Trading reported no remaining NovoCure position as of Q1 2026 after selling out during the quarter.
  • Walleye Trading sold 25,808 NovoCure shares in Q1 2026, an estimated $334K.
  • Walleye Trading first reported a position in NovoCure in Q4 2018 and held it in 14 quarters.
  • Walleye Trading's NovoCure position peaked at $2.04M in Q2 2021.
  • 222 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.